Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • China SGT-163 CAS 1099-87-2 Overview and Applications in Industry and Research

Nov . 26, 2024 01:33 Back to list

China SGT-163 CAS 1099-87-2 Overview and Applications in Industry and Research



China SGT-163 and Its Implications An Overview of CAS 1099-87-2


The chemical compound known as SGT-163, categorized under the CAS number 1099-87-2, represents a significant point of discussion within the realms of pharmacology and toxicology. This compound is a synthetic cathinone, which is part of a larger family of substances often referenced as “bath salts.” These substances have garnered attention for their psychoactive effects and their potential for abuse.


SGT-163, initially synthesized for research purposes, has been identified in various regions, prompting the need for regulatory scrutiny and public health considerations. It is important to understand the chemical structure and mechanisms of action of such compounds. SGT-163 is structurally similar to other synthetic cathinones, making it important for toxicologists and chemists to evaluate its stability, metabolism, and overall impact on human health.


Pharmacological Profile

The pharmacological profile of SGT-163 shows strong affinities for monoamine transporters, particularly those for dopamine, norepinephrine, and serotonin. By inhibiting the reuptake of these neurotransmitters, SGT-163 can lead to stimulated central nervous system activity, which is often associated with euphoria, increased energy, and heightened alertness. Yet, these desired effects can be accompanied by a series of adverse reactions, including anxiety, paranoia, heart palpitations, and even severe psychological disturbances.


As the use of SGT-163 becomes more prevalent, instances of psychological dependence and withdrawal symptoms are also being reported. This has raised alarms among health professionals, as the growing number of synthetic drugs presents challenges in treatment and prevention strategies.


Legal Status and Regulation


china sgt-163 cas 1099-87-2

china sgt-163 cas 1099-87-2

The regulatory landscape for substances like SGT-163 is complex and varies across different jurisdictions. Due to the potential for abuse and the associated health risks, many countries have moved to classify such compounds as controlled substances. In China, for example, authorities have implemented strict regulations regarding the manufacture, distribution, and possession of synthetic cathinones, including SGT-163. This legal framework aims to curtail the spread of these substances in both recreational and illicit contexts.


Public Health Implications


The emergence of SGT-163 in the illicit drug market poses significant public health challenges. Overdoses and serious health complications linked to its use have necessitated increased surveillance and testing methods to ensure that medical professionals can identify and treat affected individuals promptly. Therefore, toxicology screenings in emergency settings have become vital, enabling the detection of synthetic drugs, including SGT-163, which may not be included in standard drug testing panels.


Furthermore, education and awareness efforts aimed at the public and healthcare providers are critical. By informing these groups about the dangers of synthetic cathinones and the specific risks associated with compounds like SGT-163, it may be possible to reduce consumption and mitigate health crises arising from their use.


Conclusion


In conclusion, SGT-163 (CAS 1099-87-2) exemplifies the broader challenges presented by synthetic drugs in contemporary society. Its psychoactive properties and potential harms require continuous research and immediate regulatory responses. As we advance our understanding of such compounds, the importance of public health education, effective treatment strategies, and a robust legal framework will become increasingly essential in addressing the concerns surrounding synthetic cathinones. The complex interplay between innovation in drug synthesis and public health safety necessitates an ongoing dialogue among scientists, policymakers, and healthcare providers.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
tkTurkmen
en_USEnglish afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu tkTurkmen